Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Nasdaq powers up 83 pts into close as tech stocks bounce back

US shares are heading higher at the close on Wall Street
The Nasdaq index was firmly ahead into the close
  • US benchmarks higher into close

  • Nasdaq up over 83

  • US cruder price higher



US stocks powered higher into the close and the oil price firmed.

The Nasdaq is up over 83 points at 6,463 and the S&P 500 added over 12 at 2,509.

The benchmark Dow Jones Industrials gained almost 66 points to stand at 22,350.

US crude is up 0.48% to  US$52.13 a barrel at the time of writing.

The TSX in Toronto added over 132 points at 15,606.




US benchmarks were still higher at mid-session.

The Dow Jones added over 18 at 22,303, while the S&P 500 gained 5.48 at 2,502. The tech heavy Nasdaq gained almost 57 at 6,437.

RYB Education Inc (NASDAQ: RYB) shares added 41% after the group listed in New York and priced its initial public offering at $18.50 per share. Inc (   NASDAQ: OSTK) added almost 18% following news from the company on a new alternative trading system to be launched with joint venture partners RenGen and Argon.



US shares were  higher at the open, as FTSE 1100 in London lagged, with financial stocks and banks on Wall Street doing well.

Bank of America Corp (NYSE:BAC)  added over 2% on the day to US$25.31, while Citigroup Inc (NYSE:C) added almost 2% at US$72.25. Wells Fargo (NYSE:WFC) also went higher, adding 0.90% on the day.

The Dow Jones added over 24 at 22,308, while the S&P 500 added almost six points at 2,502. The Nasdaq added over 39 at 6,419. The oil price - West Texas Intermediate - gained 0.31% to US$52.05 each.

In Toronto, the TSX added over 32 points to stand at 15,506.

Among the most notable gainers on Nasdaq was Immune Pharmaceuticals Inc (NASDAQ:IMNP), whose shares surged over 38% to US$1.66 thanks to positive results from an ongoing Phase 2 drug trial.

It told investors that the first six subjects enrolled in the study of the company’s bertilimumab in patients with moderate to severe bullous pemphigoid (BP), an autoimmune skin disease.



US benchmarks are set to open higher mid-week after a mixed close yesterday, with Dow futures up 27 points.

The S&P 500 futures are 5.35 points higher at the time of writing, while the tech heavy Nasdaq looks to continue making gains after recent losses - up 20 points.

Twitter (NASDAQ:TWTR) shares nudged up 1.51% after -hours to US$16.84 after the social media firm said it was trialing doubling its maximum character limit on a tweet to 280 characters.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use